NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.
Physicians and other health care providers are finding molecular diagnostics to be a useful part of their practice, and the number of genetic tests available continues to grow at a rapid pace.
Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia Department of Pathology is now offering a new coronavirus test with expanded capacity to the entire state. "We have ...
BOSTON & OXFORD, England & CAMBRIDGE, England & BRISBANE, Australia--(BUSINESS WIRE)--Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic ...
SIOUX CITY - Siouxland women can now benefit from a new molecular genetic testing lab opened by Sioux City physicians that will test patient DNA for certain viruses and diseases. The Molecular Lab of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results